Anixa Biosciences Return on Equity

Anixa Biosciences (ANIX) currently reports a ROE of -72.02%. That is below the Technology sector average of 65.46%. Use the charts on this page to explore Anixa Biosciences's ROE history and peer comparisons.

Anixa Biosciences's ROE of -72.02% is lower than the Technology sector average of 65.46%. That is roughly 210.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Anixa Biosciences's current -72.02% should be judged against Technology norms (sector average: 65.46%) and against ANIX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -72.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 65.46%. From there, open related valuation or income-statement pages for Anixa Biosciences, and consider following ANIX for alerts when major investors trade the stock.

Anixa Biosciences is classified in the Technology sector. On ROE, it currently shows -72.02% versus a sector average near 65.46%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ANIX with unrelated industries.